![Murray Stewart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 27 511 $ in data 31/05/2026
Murray Willis Stewart currently works at X4 Pharmaceuticals, Inc., as Independent Director from 2023, Vivli Center For Global Clinical Research Data, as Director, VectivBio AG, as Director, and CAMP4 Therapeutics Corp., as Independent Director from 2025.
Dr. Stewart also formerly worked at Amarin Corp.
Plc, as Independent Director in 2023, VectivBio Holding AG, as Independent Director from 2021 to 2023, Rhythm Pharmaceuticals, Inc., as Chief Medical Officer from 2018 to 2021, GSK Plc, as Chief Medical Officer from 2014 to 2017, and Novelion Therapeutics, Inc., as Executive VP, Head-Research & Development from 2017 to 2018.
Dr. Stewart received his doctorate degree from The University of Southampton.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/03/2026 | 6.383 ( 0,01% ) | 27 511 $ | 31/05/2026 | |
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 29/03/2019 |
| CAMP4 THERAPEUTICS CORPORATION | Direttore/Membro del Consiglio | 18/03/2025 |
Vivli Center For Global Clinical Research Data
 Vivli Center For Global Clinical Research Data Internet Software/ServicesTechnology Services Operates as a clinical research data sharing platform | Direttore/Membro del Consiglio | - |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology Operates as biotechnology company | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| VECTIVBIO HOLDING AG | Direttore/Membro del Consiglio | 26/06/2023 |
| AMARIN CORPORATION PLC | Direttore/Membro del Consiglio | 06/03/2023 |
| RHYTHM PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 10/09/2021 |
| NOVELION THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 17/10/2018 |
| GSK PLC | Direttore Tecnico/Scientifico/R&S | 01/11/2017 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Vivli Center For Global Clinical Research Data
Vivli Center For Global Clinical Research Data Internet Software/ServicesTechnology Services Operates as a clinical research data sharing platform | Technology Services |
VectivBio Holding AG
 VectivBio Holding AG Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for rare diseases | Health Technology |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
